Haemorrhagic ulcerative duodenitis in a patient with COVID-19 infection: clinical improvement following treatment with budesonide
Open Access
- 18 October 2021
- journal article
- research article
- Published by BMJ in BMJ Open Gastroenterology
- Vol. 8 (1), e000757
- https://doi.org/10.1136/bmjgast-2021-000757
Abstract
We present a case of a male patient in his mid-30s with COVID-19-induced lung failure requiring extracorporeal membrane oxygenation, who needed an emergency oesophagogastroduodenoscopy due to major upper gastrointestinal bleeding. Endoscopy exposed severe ulcerative duodenitis with diffuse mucosal bleeding. While CT angiography did not show any signs of ischaemia, histopathology revealed duodenitis with substantial inflammatory cell infiltrates consisting of neutrophils and CD3+ T lymphocytes with equal CD4+/CD8+ distribution. Since the composition of cell infiltrates coincides with changes in inflammatory patterns of the respiratory mucosa from patients with COVID-19 and in COVID-19-associated enterocolitis, and systemic dexamethasone treatment became standard of care in ventilated intensive care unit patients with COVID-19 infection, we initiated an individualised therapeutic attempt to treat the duodenitis with topical enteral budesonide. Follow-up oesophagogastroduodenoscopies within 4 weeks of enteral budesonide administration revealed a full clinical and histological healing of the duodenal mucosa with marked reduction of neutrophilic and lymphocytic infiltrates. To our knowledge, the current report is the first description of enteral budesonide treatment of duodenitis in a patient with COVID-19 infection and warrants further investigation, whether budesonide might constitute a novel therapeutic strategy for the management of COVID-19-related intestinal mucosal damage.Keywords
This publication has 18 references indexed in Scilit:
- Gastrointestinal Bleeding in Patients With Coronavirus Disease 2019: A Matched Case-Control StudyThe American Journal of Gastroenterology, 2020
- Efficacy of local budesonide therapy in the management of persistent hyposmia in COVID-19 patients without signs of severity: A structured summary of a study protocol for a randomised controlled trialTrials, 2020
- COVID-19 and the kidney: what we think we know so far and what we don’tJournal of Nephrology, 2020
- Neutrophils, Crucial, or Harmful Immune Cells Involved in Coronavirus Infection: A Bioinformatics StudyFrontiers in Genetics, 2020
- Haemorrhagic enteritis and COVID-19: causality or coincidenceJournal of Clinical Pathology, 2020
- Evidence for Gastrointestinal Infection of SARS-CoV-2Gastroenterology, 2020
- Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infectionGut, 2020
- Ischemic enterocolitis and its differential diagnosisSeminars in Diagnostic Pathology, 2014
- Ischemic duodenitis without involvement of the large abdominal arteriesEndoscopy, 2007